Reg. no. 5593734063 · Research and experimental development on biotechnology · FLYINGE
Raaven Therapeutics AB is registered with the legal form Limited company, is based in FLYINGE and is active in Research and experimental development on biotechnology. Revenue for 2025 was 44 MSEK.
Fiscal year ending 2025-12-31 · Amounts in SEK
Net revenue
44 MSEK
▲ +222%Operating result
32.2 MSEK
▲ >+1000%Net result
19.5 MSEK
▲ +738%Employees (annual report)
6
Total assets
35.4 MSEK
Equity
20.3 MSEK
Equity ratio
75.6 %
Profit margin
44.2 %
MSEK
Raaven Therapeutics AB increased net sales by 223.1 % to 44 MSEK in 2025. Raaven Therapeutics AB lifted its operating margin from 21.1 % to 73.2 % in 2025. With an operating margin of 73.2 %, the company ranked at the 90th percentile among 302 companies in its industry. Each of the three most recent comparable fiscal periods (2023–2025) ended in profit.
Calculated by ArkivNord from filed annual reports. Positive signals from the latest annual accounts. See the Analysis tab for the full calculation behind each badge. About the methodology
Source: Bolagsverket and Statistics Sweden (SCB), public registers, updated continuously. A missing value does not mean the company is inactive.
Rows marked “named in their annual report” come from another company’s filing and are not a confirmed ownership record.
Per the signatures in the annual report for the fiscal year ending 2025-12-31.
This shows who signed the most recent parsed annual report — not a live register. Positions may have changed since filing.
Raaven Therapeutics AB's reg. no. is 5593734063.
Raaven Therapeutics AB reported revenue of 44 MSEK for the fiscal year 2025.
Yes — Raaven Therapeutics AB reported a net profit of 19.5 MSEK for 2025.
Raaven Therapeutics AB had 6 employees as of the most recently reported period (2025).
Raaven Therapeutics AB is registered under Research and experimental development on biotechnology.
Raaven Therapeutics AB is based in FLYINGE.
arkivnord